These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 12964023)

  • 1. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma.
    Boltze C; Schneider-Stock R; Quednow C; Gerlach R; Mawrin C; Hinze R; Roessner A; Hoang-Vu C
    Int J Oncol; 2003 Nov; 23(5):1323-8. PubMed ID: 14532972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis].
    Boltze C; Hoang-Vu C; Schneider-Stock R; Lehnert H; Roessner A
    Verh Dtsch Ges Pathol; 2004; 88():237-45. PubMed ID: 16892558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
    Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z; Shi HY; Nawaz Z; Zhang M
    Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
    Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
    Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
    Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
    J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
    Maass N; Hojo T; Ueding M; Lüttges J; Klöppel G; Jonat W; Nagasaki K
    Clin Cancer Res; 2001 Apr; 7(4):812-7. PubMed ID: 11309327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
    Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
    Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
    Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
    Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
    Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
    Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for DNA methylation in the control of cell type specific maspin expression.
    Futscher BW; Oshiro MM; Wozniak RJ; Holtan N; Hanigan CL; Duan H; Domann FE
    Nat Genet; 2002 Jun; 31(2):175-9. PubMed ID: 12021783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.